Cancer stem cells get energy from protein, and it’s proving to be their Achilles’ heel

CU Cancer Center study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Turning off protein metabolism kills these cells.

Will tarloxotinib finally break the HER2 barrier in lung cancer?

By pairing a potent HER2/EGFR inhibitor with a targeting mechanism specific to tumors, researchers show that tarloxotinib is far more active against lung cancer cell lines than even the most successful existing HER2/EGFR inhibitors.

Golfers Against Cancer Celebrates 10 years and $1 million dollars for cancer research

In 2009 the Denver Golfers Against Cancer (GAC) Chapter held its first gala to raise money for life-saving cancer research. In 2010, GAC added a golf tournament to accompany the gala. Now, with the support of the two events, the organization has raised over $1 million...

International study finds micro plastics in human waste

Micro plastic has made its way into the human gut. Whether or not this will have an impact on our health needs more research.

New study looks at effectiveness of combination therapy against refractory, metastatic colon cancer

If colon cancer is caught in its early stages, patients typically have a good chance of living five years past diagnosis, and beyond. However, for patients with late-stage, metastatic colon cancer, the chance drops dramatically, to a five-year survival rate of only...

Latest News from the University of Colorado Cancer Center

@CUCancerCenter on Twitter